Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 3
1990 7
1991 2
1992 1
1993 5
1994 3
1995 1
1996 1
1997 1
1998 1
2000 7
2001 6
2002 4
2003 4
2004 6
2005 7
2006 7
2007 4
2008 13
2009 14
2010 18
2011 17
2012 18
2013 17
2014 17
2015 14
2016 8
2017 8
2018 11
2019 7
2020 16
2021 13
2022 6
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.
Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ, Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, Brenton JD, Chiappinelli KB, Martins FC, Coukos G, Drapkin R, Edmondson R, Fotopoulou C, Gabra H, Galon J, Gourley C, Heong V, Huntsman DG, Iwanicki M, Karlan BY, Kaye A, Lengyel E, Levine DA, Lu KH, McNeish IA, Menon U, Narod SA, Nelson BH, Nephew KP, Pharoah P, Powell DJ Jr, Ramos P, Romero IL, Scott CL, Sood AK, Stronach EA, Balkwill FR. Bowtell DD, et al. Among authors: nephew kp. Nat Rev Cancer. 2015 Nov;15(11):668-79. doi: 10.1038/nrc4019. Nat Rev Cancer. 2015. PMID: 26493647 Free PMC article. Review.
In vivo tumor growth of high-grade serous ovarian cancer cell lines.
Mitra AK, Davis DA, Tomar S, Roy L, Gurler H, Xie J, Lantvit DD, Cardenas H, Fang F, Liu Y, Loughran E, Yang J, Sharon Stack M, Emerson RE, Cowden Dahl KD, V Barbolina M, Nephew KP, Matei D, Burdette JE. Mitra AK, et al. Among authors: nephew kp. Gynecol Oncol. 2015 Aug;138(2):372-7. doi: 10.1016/j.ygyno.2015.05.040. Epub 2015 Jun 5. Gynecol Oncol. 2015. PMID: 26050922 Free PMC article.
Complete Transcriptome RNA-Seq.
Miller DF, Yan P, Fang F, Buechlein A, Kroll K, Frankhouser D, Stump C, Stump P, Ford JB, Tang H, Michaels S, Matei D, Huang TH, Chien J, Liu Y, Rusch DB, Nephew KP. Miller DF, et al. Among authors: nephew kp. Methods Mol Biol. 2017;1513:141-162. doi: 10.1007/978-1-4939-6539-7_10. Methods Mol Biol. 2017. PMID: 27807835
TONSL Is an Immortalizing Oncogene and a Therapeutic Target in Breast Cancer.
Khatpe AS, Dirks R, Bhat-Nakshatri P, Mang H, Batic K, Swiezy S, Olson J, Rao X, Wang Y, Tanaka H, Liu S, Wan J, Chen D, Liu Y, Fang F, Althouse S, Hulsey E, Granatir MM, Addison R, Temm CJ, Sandusky G, Lee-Gosselin A, Nephew K, Miller KD, Nakshatri H. Khatpe AS, et al. Among authors: nephew k. Cancer Res. 2023 Apr 14;83(8):1345-1360. doi: 10.1158/0008-5472.CAN-22-3667. Cancer Res. 2023. PMID: 37057595 Free PMC article.
Epigenetics and ovarian cancer.
Nephew KP, Balch C, Zhang S, Huang TH. Nephew KP, et al. Cancer Treat Res. 2009;149:131-46. doi: 10.1007/978-0-387-98094-2_6. Cancer Treat Res. 2009. PMID: 19763434 Review. No abstract available.
Epithelial ovarian cancer experimental models.
Lengyel E, Burdette JE, Kenny HA, Matei D, Pilrose J, Haluska P, Nephew KP, Hales DB, Stack MS. Lengyel E, et al. Among authors: nephew kp. Oncogene. 2014 Jul 10;33(28):3619-33. doi: 10.1038/onc.2013.321. Epub 2013 Aug 12. Oncogene. 2014. PMID: 23934194 Free PMC article. Review.
Molecular determinants of chemotherapy resistance in ovarian cancer.
Cooley M, Fang P, Fang F, Nephew KP, Chien J. Cooley M, et al. Among authors: nephew kp. Pharmacogenomics. 2015 Nov;16(16):1763-7. doi: 10.2217/pgs.15.130. Epub 2015 Nov 10. Pharmacogenomics. 2015. PMID: 26554863 Free article. No abstract available.
253 results